KALA BIO, Inc.
KALA
$0.93
-$0.18-15.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.05% | 7.55% | -15.29% | -9.13% | -11.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.42% | 12.88% | -9.56% | 1.26% | -8.93% |
| Operating Income | -11.42% | -12.88% | 9.56% | -1.26% | 8.93% |
| Income Before Tax | 15.49% | -16.45% | 24.22% | 5.24% | -2.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.49% | -16.45% | 24.22% | 5.24% | -2.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.49% | -16.45% | 24.22% | 5.24% | -2.83% |
| EBIT | -11.42% | -12.88% | 9.56% | -1.26% | 8.93% |
| EBITDA | -10.82% | -12.90% | 9.63% | -1.28% | 8.84% |
| EPS Basic | 44.47% | 45.82% | 66.41% | 45.25% | 43.33% |
| Normalized Basic EPS | 15.37% | 46.72% | 66.03% | 4.56% | 55.01% |
| EPS Diluted | 44.47% | 45.82% | 66.41% | 45.25% | 43.33% |
| Normalized Diluted EPS | 15.37% | 46.72% | 66.03% | 4.56% | 55.01% |
| Average Basic Shares Outstanding | 52.18% | 114.94% | 125.58% | 73.07% | 81.46% |
| Average Diluted Shares Outstanding | 52.18% | 114.94% | 125.58% | 73.07% | 81.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |